Related Experiment Video
Updated: Jun 4, 2026

Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
Published on: September 19, 2025
Severe H1N1-associated acute respiratory failure in immunocompromised children
Lama Elbahlawan1, Aditya H Gaur, Wayne Furman
1Division of Critical Care Medicine, St. Jude Children's Research Hospital, Tennessee 38105-3678, USA. lama.elbahlawan@stjude.org
Insights
Critically ill children with cancer receiving chemotherapy who developed severe H1N1 influenza and acute respiratory failure (ARF) all survived with aggressive intensive care. Early detection of oseltamivir-resistant H1N1 is crucial for this vulnerable population.
Area of Science:
- Pediatric Critical Care Medicine
- Infectious Diseases
- Pediatric Oncology
Background:
- Severe pandemic influenza A (H1N1) infection poses a high mortality risk, particularly for children with malignancy.
- Immunosuppression from chemotherapy or underlying disease increases H1N1-associated acute respiratory failure (ARF) risk in pediatric oncology patients.
Purpose of the Study:
- To describe the clinical course and outcomes of critically ill pediatric oncology and hematology patients experiencing H1N1-associated ARF.
- To evaluate the effectiveness of intensive care interventions in this high-risk group.
Main Methods:
- Retrospective case series of five pediatric oncology/hematology patients admitted to the ICU with H1N1 infection and ARF during the 2009-2010 influenza season.
- Detailed analysis of clinical course, ventilatory support, medical management, and patient outcomes.
Main Results:
- All five patients, despite requiring mechanical ventilation and intensive supportive care (including high-frequency oscillatory ventilation and nitric oxide), survived to hospital discharge.
- Oseltamivir resistance was noted in two patients, necessitating a switch to intravenous zanamivir.
- Mean mechanical ventilation duration was 24 days and mean ICU stay was 37 days.
Conclusions:
- Aggressive supportive care is vital for managing H1N1-related ARF in immunocompromised children with cancer.
- Early identification and management of oseltamivir-resistant H1N1 infections are critical for favorable outcomes in this vulnerable pediatric population.
Background:
Severe pandemic influenza A (H1N1) infection can lead to acute respiratory failure (ARF) with associated high mortality. Children with malignancy may be at higher risk of H1N1-associated ARF because of underlying primary disease or immunosuppression associated with chemotherapy.
Procedure:
We describe the clinical course and outcome of critically ill pediatric oncology/hematology patients with H1N1-associated ARF.
Results:
Five patients were admitted to the St. Jude Children's Research Hospital (SJCRH) ICU with H1N1 infection during the 2009-2010 influenza season. Underlying diagnoses included 2 patients with acute lymphoblastic leukemia and one each with neuroblastoma, brainstem glioma, and hemolytic anemia secondary to pyruvate kinase deficiency. All patients were mechanically ventilated secondary to ARF following unsuccessful trials of non-invasive ventilatory support. The majority of patients (4/5) required inotropic support, and none required dialysis. Further measures to support their ARF included high frequency oscillatory ventilation in 2 patients, nitric oxide in 3 patients, and surfactant in 1 patient. Three patients had bronchopleural air leak. All patients received oseltamivir; however, 2 were switched to intravenous zanamivir once resistance to oseltamivir was documented. Mean duration of mechanical ventilation was 24 ± 6.8 days and mean duration of ICU admission was 37 ± 12 days. All patients survived to hospital discharge.
Conclusion:
Our series suggests an overall favorable outcome in immunocompromised children with H1N1-related ARF. Our experience underscores the value of aggressive support during H1N1-related ARF, and early detection and management of oseltamivir-resistant H1N1 infection in this high-risk population.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Influenza

